For Women’s History Month, this research Q&A focuses on Olivera Finn, PhD, and her experience as a female researcher. Dr. Finn is a member of the Cancer Immunology and Immunotherapy Program at UPMC Hillman Cancer Center and distinguished professor in…
According to the American Medical Association, racial and ethnic minorities experience a lower quality of health care, are less likely to receive routine care, and face higher rates of morbidity and mortality than nonminorities. When it comes to cancer patients,…
UPMC Hillman Cancer Center is pleased to welcome Renfeng Li, PhD. Dr. Li joined January 1, 2023 and is associate professor of Microbiology and Molecular Genetics and a member of the Cancer Virology research program at UPMC Hillman. His research…
UPMC Hillman Cancer Center is pleased to welcome Angela Mazul, PhD. Dr. Mazul is assistant professor in the Department of Otolaryngology at the University of Pittsburgh and a member of UPMC Hillman. Dr. Mazul will focus on head and neck…
Researchers at the UPMC Hillman Cancer Center Tumor Microenvironment Center developed a new model that can be used by immunologists to further the understanding of CAR-T cell biology and identified a new possible human CAR-T cell target. The model published…
Yael Schenker, MD, MAS, has been appointed to the position of Associate Director for Education and Training, focusing on clinical investigators at UPMC Hillman Cancer Center. Dr. Schenker will work closely and in partnership with Associate Director Chris Bakkenist, who…
This research highlight focuses on Lyn Robertson, DrPH, MSN, BSN — Director of Cancer Screening and External Partnerships for Health Equity and Community Outreach and Engagement at UPMC Hillman Cancer Center. One of Dr. Robertson’s main areas of interest is…
The University of Pittsburgh was awarded a five-year, $11.2 million grant from the National Institutes of Health (NIH) to support a Head and Neck Cancer Specialized Program of Research Excellence (SPORE) in 2022. The award will be led by Robert…
Jason J. Luke, MD, FACP, will be the Interim Associate Director for Clinical Research at UPMC Hillman Cancer Center beginning February 1, 2023. Dr. Luke is currently Director of Hillman’s Immunotherapy and Drug Development Center and a member of the…
In 2022, we at UPMC Hillman Cancer Center greatly expanded the capabilities for the research that is done here every day to envision life without cancer. We expanded our footprint, welcomed exceptional leadership and faculty to our center, and launched…
